A carregar...
Disease-modifying therapy for proteinopathies: Can the exception become the rule?
Disease-modifying therapies for proteinopathies are urgently needed yet clinical trials for the major neurodegenerative diseases, Alzheimer’s and Parkinson’s, have been failing at an alarming rate leaving patients and caregivers scrambling for any sign of hope. At the same time, for one family of pr...
Na minha lista:
| Publicado no: | Prog Mol Biol Transl Sci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032046/ https://ncbi.nlm.nih.gov/pubmed/31699321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.pmbts.2019.07.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|